Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

Sharma, Sushil; Mathur, A G; Pradhan, Sapna; Singh, D B; Gupta, Sparsh

doi:10.4103/0976-500X.77118

ResearchArchivesVol. 2 | Issue 1 | 2011 | pp. 49–51Open Access

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

¹^*,
¹,
¹,
¹,
¹

¹Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.

Correspondence: Sushil Sharma
Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.
Email: sushkehar@rediffmail.com

Published: Jan 1, 2011

DOI: https://doi.org/10.4103/0976-500X.77118
Article URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-2-1-49
PDF URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-2-1-49.pdf

Abstract

No abstract available.

Subject

Readers Also Viewed

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026

Review Article

Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions

Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei

Jan 1, 2025

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026